Polar Capital Holdings’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.6M | Buy |
2,703,256
+80,217
| +3% | +$2.51M | 0.44% | 61 |
|
|
2025
Q1 | $88M | Sell |
2,623,039
-74,618
| -3% | -$2.5M | 0.54% | 50 |
|
|
2024
Q4 | $106M | Buy |
2,697,657
+253,012
| +10% | +$9.92M | 0.59% | 47 |
|
|
2024
Q3 | $96.2M | Sell |
2,444,645
-91,413
| -4% | -$3.6M | 0.46% | 50 |
|
|
2024
Q2 | $98.9M | Sell |
2,536,058
-76,050
| -3% | -$2.97M | 0.58% | 45 |
|
|
2024
Q1 | $112M | Sell |
2,612,108
-454,520
| -15% | -$19.6M | 0.59% | 42 |
|
|
2023
Q4 | $141M | Buy |
3,066,628
+62,881
| +2% | +$2.9M | 0.87% | 21 |
|
|
2023
Q3 | $103M | Sell |
3,003,747
-18,324
| -0.6% | -$626K | 0.76% | 34 |
|
|
2023
Q2 | $116M | Buy |
3,022,071
+5,253
| +0.2% | +$202K | 0.59% | 30 |
|
|
2023
Q1 | $108M | Sell |
3,016,818
-29,056
| -1% | -$1.04M | 0.7% | 35 |
|
|
2022
Q4 | $120M | Buy |
3,045,874
+383,152
| +14% | +$15.1M | 0.96% | 22 |
|
|
2022
Q3 | $96.1K | Buy |
2,662,722
+122,663
| +5% | +$4.43K | 0.61% | 40 |
|
|
2022
Q2 | $77.3K | Buy |
2,540,059
+350,000
| +16% | +$10.6K | 0.45% | 54 |
|
|
2022
Q1 | $67K | Buy |
2,190,059
+502,015
| +30% | +$15.3K | 0.3% | 80 |
|
|
2021
Q4 | $52.7K | Buy |
+1,688,044
| New | +$52.7K | 0.2% | 97 |
|